Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aptose Biosciences Inc (OP:APTOF)

0.8001 UNCHANGED
Streaming Delayed Price Updated: 3:55 PM EDT, Jun 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.8001
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.8001
Today's Range 0.8001 - 0.8001
52wk Range 0.6363 - 4.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib in Triplet Therapy for AML
From Aptose Biosciences, Inc.
Via GlobeNewswire
Aptose Provides Corporate Updates
From Aptose Biosciences, Inc.
Via GlobeNewswire

Performance

YTD
-60.2%
-60.2%
1 Month
-54.5%
-54.5%
3 Month
-60.2%
-60.2%
6 Month
-60.2%
-60.2%
1 Year
-60.2%
-60.2%

More News

Read More
Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2025 EHA Congress
From Aptose Biosciences, Inc.
Via GlobeNewswire
Aptose Announces Results from Annual and Special Meeting of Shareholders
From Aptose Biosciences, Inc.
Via GlobeNewswire
Aptose Announces Dosing of First Patient with 120 mg of Tuspetinib in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy after Dose Escalation Decision by Safety Review Committee
From Aptose Biosciences, Inc.
Via GlobeNewswire
Aptose Selected for Prestigious Oral Presentation of Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2025 EHA Congress
From Aptose Biosciences, Inc.
Via GlobeNewswire
Aptose Reports First Quarter 2025 Results
From Aptose Biosciences, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Aptose Biosciences Inc publicly traded?
Yes, Aptose Biosciences Inc is publicly traded.
What exchange does Aptose Biosciences Inc trade on?
Aptose Biosciences Inc trades on the OTC Traded
What is the ticker symbol for Aptose Biosciences Inc?
The ticker symbol for Aptose Biosciences Inc is APTOF on the OTC Traded
What is the current price of Aptose Biosciences Inc?
The current price of Aptose Biosciences Inc is 0.8001
When was Aptose Biosciences Inc last traded?
The last trade of Aptose Biosciences Inc was at 06/25/25 03:55 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.